VISACards AcceptedFree Shipping Over $300GTA Third-Party TestedHPLC Purity and Bacterial Endotoxin TestedShips Canada-Wide3+ Vials — 10% Off5+ Vials — 20% Off10+ Vials — 40% OffVISACards AcceptedFree Shipping Over $300GTA Third-Party TestedHPLC Purity and Bacterial Endotoxin TestedShips Canada-Wide3+ Vials — 10% Off5+ Vials — 20% Off10+ Vials — 40% Off
Out of stock

TIRZ

20 mg (lyophilized)

Purity:

TBD

TIRZ 20 mg (lyophilized) research vial

Cap colour is for illustration purposes only

Research peptide · RUO · Canada

TIRZ

20 mg (lyophilized)

Formula
$129CAD · per vial

+ $25 flat-rate shipping · free at $300+ · Interac e-Transfer · VISA

Volume pricing

3+ vials10% off$116.10/ea
5+ vials20% off$103.20/ea
10+ vials40% off$77.40/ea
1
Inquire
PurityTBD
Storage-20°C
FormLyophilized
TestingHPLC
🏦Interac e-Transfer
COA policy·Returns

About this compound

TIRZ is a synthetic dual-agonist peptide that simultaneously activates both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R). It is a 39-amino acid peptide with a C20 fatty diacid moiety enabling albumin binding and extended half-life. This 20 mg presentation provides a higher-concentration option for preclinical dose-response and pharmacokinetic research protocols. Currently in third-party testing — batch COA and confirmed purity will be posted once results clear.

Storage and handling

Lyophilized storage

Store at -20°C lyophilized, away from moisture and UV light. Keep vials sealed until use. Stable for 2+ years in a non-frost-free freezer.

Preclinical research references

Provided for informational context only. All cited studies involve preclinical or in vitro models. Results do not predict human safety or efficacy. These references do not constitute medical claims.

  • Diet-induced obese mouse models demonstrated that TIRZ produced significantly greater reductions in body weight and fat mass compared to selective GLP-1R agonists at equivalent doses, attributed to synergistic dual-receptor engagement (Coskun et al., 2022)
  • Rodent metabolic studies observed that TIRZ normalized fasting glucose, improved insulin sensitivity, and reduced triglyceride levels in a dose-dependent manner across diabetic and obese animal models (Min et al., 2021)
  • Primate pharmacokinetic studies confirmed extended plasma half-life and consistent receptor occupancy supporting extended dosing intervals, with favorable subcutaneous bioavailability profiles (Urva et al., 2022)
  • Mouse energy expenditure studies showed TIRZ increased metabolic rate and reduced food intake through central GLP-1R and GIPR co-activation in hypothalamic circuits, independent of lean mass changes (Samms et al., 2021)

Shipping & returns

Shipping

1–5 business days (5–7 for BC, NL and remote areas), Canada-wide tracked courier, double tamper-proof packaging.

Returns

All sales final. Damaged or incorrect orders must be reported within 24 hours with photos.

Quality assurance

Every batch independently tested for purity. COA on file and available before purchase.

FAQ — TIRZ

For research use only. Not for human or veterinary administration.

Research updates

Stay ahead of new batches.

New compounds, COA releases, batch testing results, and research content — straight to your inbox.

Research Use Only (RUO): All products are strictly for laboratory research. Not for human or veterinary use. Full disclaimer →